Navigation Links
The Wistar Institute collaborates with the Coriell Institute to distribute cell lines
Date:3/25/2008

(PHILADELPHIA) Cell lines developed by scientists at The Wistar Institute in Philadelphia have recently been made available to researchers around the globe through the catalog collection at the Coriell Institute for Medical Research of Camden, N.J.

The collaboration means that scientists at a variety of research organizations can access biological materials developed at Wistar for use in the development of vaccines and treatments for cancer and other deadly diseases.

We are pleased to make these valuable materials widely available to the research community through the Coriell Biobank, said Russel E. Kaufman, M.D., president and CEO of Wistar. This collaboration with Coriell, who is a leader in the storage and distribution of biological materials, means that some of the key tools used in the potentially lifesaving work of Wistar scientists will be made available worldwide.

The initial Wistar collection to be distributed by Coriell includes hybridoma cell lines that produce monoclonal antibodies that measure peoples exposure to influenza viruses and response to vaccines. These cell lines were developed over the course of 30 years by renowned influenza researcher Walter Gerhard, M.D., who retired from Wistar in 2007. The monoclonal antibodies produced by these cell lines are useful in the development of vaccines against a variety of influenza strains, including pandemic influenza, Kaufman said.

Wistar and Coriell also are working to add melanoma cell lines developed in the laboratory of Wistar researcher Meenhard Herlyn, D.V.M., D.Sc., to the Wistar collection at Coriell. Cell lines amassed by Herlyn represent one of the most comprehensive melanoma cell line collections in the world, Kaufman said, and may be useful in developing drugs to treat melanoma and other cancers.

Coriell is pleased to partner with The Wistar Institute and bring together the knowledge, talents and vision of two established institutions that are international leaders in basic biomedical research, said Michael Christman, Ph.D., president and CEO of The Coriell Institute. Through this partnership we will further expand the distribution of cell lines to researchers who are working to discover cures for diseases and improve healthcare worldwide.

Our hope is that this new partnership to house and distribute these cell lines is only the beginning of further collaborative work to support biomedical research and improved public health.


'/>"/>

Contact: Abbey J. Porter
aporter@wistar.org
215-898-3943
The Wistar Institute
Source:Eurekalert

Related medicine news :

1. Novel vaccine concept developed by scientists at the Wistar Institute
2. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
3. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
4. LifeNet Health Establishes The Skin & Wound Allograft Institute
5. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
6. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
7. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
8. The Integrated Benefits Institute Offers Largest Benchmarking Database in U.S. Spanning Disability and Workers Compensation Programs
9. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
10. Bullying Prevention Institute Designed to Empower Change in Schools
11. Southern Research Institutes Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , The healthcare industry in the United States has undergone major changes over the ... needing to have a doctor’s order to get a blood test or other lab ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... Chain”: an inspirational story for those shackled by the chains of a broken life. ... writer and a woman of great faith and wisdom. She is a great motivational ... born and raised in Vero Beach, Florida and has dedicated her life and ministry to ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... of disease. It’s reaching out to a patient who feels isolated. It’s developing ... amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three renowned ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
(Date:8/3/2017)... -- Opioid addiction and other drugs of abuse, blood poisoning ... outcomes, were problems taken on directly as laboratory professionals, ... them, met this week. This according to Kalorama Information. ... abuse, procalcitonin and acute kidney injury were key focuses ... in San Diego, CA.  Mechanisms ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: